Globus Medical currently trades at $75.69 per share and has shown little upside over the past six months, posting a middling ...

Globus Spirits' craft business is now its fastest-growing vertical..It is targeting about 20,000-25,000 cases of single malt ...

In an effort to help travel advisors elevate their social media presence, Globus has partnered with social-media management ...

At CinemaCon in Las Vegas today, the Marvel Studios portion of Disney’s presentation featured the debut of brand new footage from The Fantastic Four: First Steps, including the first look ...

Globus Medical (NYSE:GMED) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the ...

Globus Medical GMED has been analyzed by 5 analysts ... Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential ...

“All major defense-acquisitions programs will be reviewed” to determine if they are complying with the administration’s new policy goals that emphasize “speed, flexibility and execution ...

The Trump administration is canceling funding for the U.S. Global Change Research Program, the entity that produces the federal government’s signature climate change study, according to three ...

April 9 (UPI) --Pharmaceuticals produced in China could become costlier after President Donald Trump announced his intention to impose a "major tariff on pharmaceuticals." Trump said he would ...

President Trump said Tuesday his administration soon would announce “major” tariffs on pharmaceuticals, adding to the tariffs he has already imposed on most goods entering the United States ...

President Donald Trump said at an event Tuesday that "a major tariff" was coming to the pharmaceutical industry. The sector was exempted from the sweeping tariffs that were announced last week and ...

Earlier this week CNBC revealed most major airlines like American, Delta and Southwest slashed their first-quarter forecasts citing weaker-than-expected corporate and leisure bookings.